You are on page 1of 35

Comparison of pharmaceutical sales in the markets of BRIC, EU5, US

and Japan, 2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Average total health expenditure as a proportion of GDP for BRIC, EU5
and the US, 2000-04

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: WHO
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Healthcare expenditures across the four BRIC countries, 2004

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: WHO
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Comparison of spends on pharmaceuticals between the US, 5 major EU
markets and the BRIC markets, 2004

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: WHO
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Private healthcare expenditure as a percentage of total healthcare
expenditure in the BRIC countries, 2004

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: WHO
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Structural challenges to pharmaceutical marketers in the BRIC
countries

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: Author’s research & analysis
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Major challenges in healthcare reform in the BRIC countries

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: Author’s research & analysis
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Average total health expenditure as % of GDP for Brazil and the
BRIC economies, 2000-04

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: WHO
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Summary structure of Brazilian healthcare system

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: Author’s Research, PAHO
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Summary structure of the Russian healthcare system

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: Author’s Research, WHO
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Average total health expenditure as % of GDP for Russia and the
BRIC economies, 2000-04

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: Author’s Research, WHO
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Summary structure of the Indian healthcare system

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: Author’s Research, WHO
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Average total health expenditure as % of GDP for India and the
BRIC economies, 2000-04

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: WHO
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Summary structure of Chinese healthcare system

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: WHO, Author’s research
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Average total health expenditure as % of GDP for China and the
BRIC economies, 2000-04

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: WHO
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Average private health expenditure for China, 2000-04

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: WHO
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Cardiovascular market breakdown by therapy area sales for individual
markets of BRIC, 2001-2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
CNS market breakdown by therapy area sales for individual markets of
BRIC, 2001-2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Cancer market breakdown by therapy area sales for individual markets
of BRIC, 2001-2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Respiratory market breakdown by therapy area sales for individual
markets of BRIC, 2001-2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Anti-infectives market breakdown by therapy area sales for individual
markets of BRIC, 2001-2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Comparison of sales in the global and BRIC markets by product
category, 2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Comparison of sales in the BRIC market by product category, 2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Penetration of original brands across therapy areas in the
BRIC markets, 2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Forecast prospects for market development of major categories of
brands by indication, 2006-11

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Breakdown of the leading pharmaceutical companies in the
BRIC markets, 2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS; Author’s Research & Analysis
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Growth dynamics of the leading pharmaceutical companies in Brazil,
2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Growth dynamics of the leading pharmaceutical companies in Russia,
2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Growth dynamics of the leading pharmaceutical companies in India,
2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Growth dynamics of leading pharmaceutical companies in China, 2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Presence of multinational pharmaceutical players in the BRIC market,
2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS; Author’s Research & Analysis
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Presence of medium-sized international pharmaceutical players in the
BRIC market, 2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS; Author’s Research & Analysis
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Presence of domestic Brazilian pharmaceutical players in the
BRIC market, 2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Presence of domestic Indian pharmaceutical players in the
BRIC market, 2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006
Presence of domestic Chinese pharmaceutical players in the
BRIC market, 2005

From: Pharmaceutical Growth Opportunities in Brazil, Russia, India and China. Source: IMS
Created for Global User, Novartis- Global License. IP Address: 160.62.4.10
© Business Insights Limited, 2006

You might also like